![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 39, 27997-28002, September 24, 1999
From Retroviral Gag protein is sufficient to produce
Gag virus-like particles when expressed in higher eukaryotic cells.
Here we describe the in vitro assembly reaction of human
immunodeficiency virus Gag protein, which consists of two sequential
steps showing the optimal conditions for each reaction. Following
expression and purification, Gag protein lacking only the C-terminal p6
domain was present as a monomer (50 kDa) by velocity sedimentation
analysis. Initial assembly of the Gag protein to 60 S intermediates
occurred by dialysis at 4 °C in low salt at neutral to alkaline pH.
However, higher order of assembly required incubation at 37 °C and
was facilitated by the addition of Mg2+. Prolonged
incubation under these conditions produced complete assembly (600 S),
equivalent to Gag virus-like particles obtained from Gag-expressing
cells. Neither form disassembled by treatment with nonionic detergent,
suggesting that correct assembly might occur in vitro.
Electron microscopic observation confirmed that the 600 S assembly
products were spherical particles similar to authentic immature human
immunodeficiency virus particles. The latter assembly stage but not the
former was accelerated by the addition of RNA although not inhibited by
RNaseA treatment. These results suggest that Gag protein alone
assembles in vitro, but that additional RNA facilitates the
assembly reaction.
In Vitro Assembly of Human Immunodeficiency Virus
Type 1 Gag Protein
,
The Kitasato Institute, Shirokane 5-9-1, Minato-ku, Tokyo 108-8642, Japan and ¶ Department of
Microbiology, Osaka Medical College, Daigaku-cho 2-7, Takatsuki,
Osaka 569-8686, Japan
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Morikawa, T. Goto, D. Yasuoka, F. Momose, and T. Matano Defect of Human Immunodeficiency Virus Type 2 Gag Assembly in Saccharomyces cerevisiae J. Virol., September 15, 2007; 81(18): 9911 - 9921. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ivanov, O. V. Tsodikov, J. Kasanov, T. Ellenberger, G. Wagner, and T. Collins Domain-swapped dimerization of the HIV-1 capsid C-terminal domain PNAS, March 13, 2007; 104(11): 4353 - 4358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ulbrich, S. Haubova, M. V. Nermut, E. Hunter, M. Rumlova, and T. Ruml Distinct Roles for Nucleic Acid in In Vitro Assembly of Purified Mason-Pfizer Monkey Virus CANC Proteins J. Virol., July 15, 2006; 80(14): 7089 - 7099. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mark-Danieli, N. Laham, M. Kenan-Eichler, A. Castiel, D. Melamed, M. Landau, N. M. Bouvier, M. J. Evans, and E. Bacharach Single Point Mutations in the Zinc Finger Motifs of the Human Immunodeficiency Virus Type 1 Nucleocapsid Alter RNA Binding Specificities of the Gag Protein and Enhance Packaging and Infectivity J. Virol., June 15, 2005; 79(12): 7756 - 7767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Lee, K. Nagashima, and W.-S. Hu Cooperative Effect of Gag Proteins p12 and Capsid during Early Events of Murine Leukemia Virus Replication J. Virol., April 1, 2005; 79(7): 4159 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morikawa, T. Goto, and F. Momose Human Immunodeficiency Virus Type 1 Gag Assembly through Assembly Intermediates J. Biol. Chem., July 23, 2004; 279(30): 31964 - 31972. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Ma and V. M. Vogt Nucleic Acid Binding-Induced Gag Dimerization in the Assembly of Rous Sarcoma Virus Particles In Vitro J. Virol., January 1, 2004; 78(1): 52 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Johnson, H. M. Scobie, Y. M. Ma, and V. M. Vogt Nucleic Acid-Independent Retrovirus Assembly Can Be Driven by Dimerization J. Virol., October 17, 2002; 76(22): 11177 - 11185. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Ma and V. M. Vogt Rous Sarcoma Virus Gag Protein-Oligonucleotide Interaction Suggests a Critical Role for Protein Dimer Formation in Assembly J. Virol., May 3, 2002; 76(11): 5452 - 5462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shehu-Xhilaga, M. Hill, J. A. Marshall, J. Kappes, S. M. Crowe, and J. Mak The Conformation of the Mature Dimeric Human Immunodeficiency Virus Type 1 RNA Genome Requires Packaging of Pol Protein J. Virol., March 27, 2002; 76(9): 4331 - 4340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Hill, C. W. Hooker, D. Harrich, S. M. Crowe, and J. Mak Gag-Pol Supplied in trans Is Efficiently Packaged and Supports Viral Function in Human Immunodeficiency Virus Type 1 J. Virol., August 1, 2001; 75(15): 6835 - 6840. [Abstract] [Full Text] |
||||
![]() |
M. Tritel and M. D. Resh The Late Stage of Human Immunodeficiency Virus Type 1 Assembly Is an Energy-Dependent Process J. Virol., June 15, 2001; 75(12): 5473 - 5481. [Abstract] [Full Text] |
||||
![]() |
F. Yu, S. M. Joshi, Y. M. Ma, R. L. Kingston, M. N. Simon, and V. M. Vogt Characterization of Rous Sarcoma Virus Gag Particles Assembled In Vitro J. Virol., March 15, 2001; 75(6): 2753 - 2764. [Abstract] [Full Text] |
||||
![]() |
N. A. Jewell and L. M. Mansky In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly J. Gen. Virol., August 1, 2000; 81(8): 1889 - 1899. [Full Text] |
||||
![]() |
M. Tritel and M. D. Resh Kinetic Analysis of Human Immunodeficiency Virus Type 1 Assembly Reveals the Presence of Sequential Intermediates J. Virol., July 1, 2000; 74(13): 5845 - 5855. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |